Herbert Cooper

1.6k total citations
33 papers, 1.4k citations indexed

About

Herbert Cooper is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Herbert Cooper has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Herbert Cooper's work include Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (12 papers) and Blood properties and coagulation (10 papers). Herbert Cooper is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (12 papers) and Blood properties and coagulation (10 papers). Herbert Cooper collaborates with scholars based in United States, France and India. Herbert Cooper's co-authors include Robert H. Wagner, K. M. Brinkhous, J. Allain, Thomas R. Griggs, W. Keith Hoots, William P. Webster, C. Thomas Kisker, Gerald Gilchrist, Diana S. Beardsley and Amy Shapiro and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Herbert Cooper

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Cooper United States 19 1.1k 254 225 126 96 33 1.4k
Dudley P. Jackson United States 14 614 0.6× 336 1.3× 189 0.8× 81 0.6× 83 0.9× 22 1.2k
Robert T. Breckenridge United States 16 529 0.5× 151 0.6× 226 1.0× 94 0.7× 80 0.8× 36 926
H. Bartels Germany 18 351 0.3× 167 0.7× 252 1.1× 74 0.6× 32 0.3× 42 924
Jerome Teitel Canada 23 1.2k 1.1× 83 0.3× 324 1.4× 164 1.3× 135 1.4× 81 1.6k
Richard B. Counts United States 13 700 0.6× 267 1.1× 160 0.7× 201 1.6× 63 0.7× 21 1.4k
Frauke Bergmann Germany 18 703 0.6× 64 0.3× 185 0.8× 179 1.4× 180 1.9× 42 1.1k
Mariasanta Napolitano Italy 22 711 0.7× 120 0.5× 337 1.5× 98 0.8× 116 1.2× 117 1.3k
Renu Saxena India 21 967 0.9× 92 0.4× 417 1.9× 81 0.6× 49 0.5× 123 1.3k
Angelika Bátorová Slovakia 22 1.5k 1.4× 149 0.6× 316 1.4× 103 0.8× 83 0.9× 77 1.7k
Kaan Kavaklı Türkiye 19 755 0.7× 80 0.3× 269 1.2× 167 1.3× 35 0.4× 81 1.2k

Countries citing papers authored by Herbert Cooper

Since Specialization
Citations

This map shows the geographic impact of Herbert Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Cooper more than expected).

Fields of papers citing papers by Herbert Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Cooper. The network helps show where Herbert Cooper may publish in the future.

Co-authorship network of co-authors of Herbert Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Cooper. A scholar is included among the top collaborators of Herbert Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Cooper. Herbert Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutchinson, Raymond J., Paul S. Gaynon, Harland N. Sather, et al.. (2003). Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881. Journal of Clinical Oncology. 21(9). 1790–1797. 35 indexed citations
2.
Cooper, Herbert. (2002). A History of Blood Coagulation. Mayo Clinic Proceedings. 77(8). 880–880. 10 indexed citations
3.
4.
Rackoff, Wayne, Q. J. Ge, Harland N. Sather, et al.. (1999). Central Venous Catheter Use and the Risk of Infection in Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 21(4). 260–267. 28 indexed citations
5.
Aledort, Louis M., Diana S. Beardsley, Herbert Cooper, et al.. (1998). Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors. Thrombosis and Haemostasis. 80(12). 912–918. 288 indexed citations
6.
Arkin, Steven, Herbert Cooper, J. Hutter, et al.. (1998). Activated Recombinant Human Coagulation Factor VII Therapy for Intracranial Hemorrhage in Patients with Hemophilia A or B with Inhibitors. Pathophysiology of Haemostasis and Thrombosis. 28(2). 93–98. 60 indexed citations
8.
Binnie, Cameron G., Robert H. Wagner, Herbert Cooper, & Jan Hermans. (1985). Parallel characterization of bovine von Willebrand protein (factor VIII-associated protein) by light scattering and SDS gel electrophoresis. Thrombosis Research. 40(4). 523–532. 5 indexed citations
9.
Hoots, W. Keith, N A Carrell, Robert H. Wagner, Herbert Cooper, & Jan McDonagh. (1981). A Naturally Occurring Antibody That Inhibits Fibrin Polymerization. New England Journal of Medicine. 304(15). 857–861. 31 indexed citations
10.
Lamb, M. A., et al.. (1981). The multimeric distribution of factor VIII-related antigen studied by an improved crossed-immunoelectrophoresis technique.. PubMed. 98(5). 751–63. 11 indexed citations
11.
Cooper, Herbert, Kenneth J. Clemetson, & E. F. Lüscher. (1979). Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): An integral membrane glycoprotein. Proceedings of the National Academy of Sciences. 76(3). 1069–1073. 31 indexed citations
13.
Cooper, Herbert, et al.. (1975). Disappearance of Canine Small Active Factor VIII Fragment Following Transfusion in Hemophilic Dogs. Thrombosis and Haemostasis. 1 indexed citations
14.
Allain, J., Herbert Cooper, Robert H. Wagner, & K. M. Brinkhous. (1975). Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.. PubMed. 85(2). 318–28. 270 indexed citations
15.
Cooper, Herbert & Robert H. Wagner. (1974). The Defect in Hemophilic and von Willebrand's Disease Plasmas Studied by a Recombination Technique. Journal of Clinical Investigation. 54(5). 1093–1099. 37 indexed citations
16.
Cooper, Herbert, Thomas R. Griggs, & Robert H. Wagner. (1973). Factor VIII Recombination After Dissociation by CaCl 2. Proceedings of the National Academy of Sciences. 70(8). 2326–2329. 82 indexed citations
17.
Griggs, Thomas R., Herbert Cooper, William P. Webster, Robert H. Wagner, & K. M. Brinkhous. (1973). Plasma Aggregating Factor (Bovine) for Human Platelets: A Marker for Study of Antihemophilic and von Willebrand Factors. Proceedings of the National Academy of Sciences. 70(10). 2814–2818. 50 indexed citations
18.
Cooper, Herbert, E. J. Walter Bowie, & Charles A. Owen. (1972). Pitfalls of the Microtiter System for Serial Dilutions and Standardization Using Radioiodinated Albumin. American Journal of Clinical Pathology. 57(3). 332–335. 4 indexed citations
19.
Cooper, Herbert, et al.. (1971). PARADOXIC CHANGES IN PLATELETS AND FIBRINOGEN IN CHRONICALLY INDUCED INTRAVASCULAR COAGULATION. Mayo Clinic Proceedings. 46(8). 521–523.
20.
Owen, Caroline A., Herbert Cooper, & E. J. Walter Bowie. (1971). Increased Fibrinolytic Split Products in Normal Dog Serum. Experimental Biology and Medicine. 138(3). 1073–1074. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026